Stockreport

Vericel Receives FDA Fast Track Designation for Ixmyelocel-T, an Investigational Product for the Treatment of Patients with Advanced Heart Failure Due to Ischemic Dilated Cardiomyopathy

Vericel Corporation  (VCEL) 
Last vericel corporation earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.vcel.com/investor-relations
PDF CAMBRIDGE, Mass., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of p [Read more]